Showing results (91-100 of 141) with videos related to
Sort By:
Pageof 15
Nature Communications|October 6, 2015
Systematic analysis of somatic mutations impacting gene expression in 12 tumour typesJiarui Ding, Melissa K McConechy, Hugo M Horlings, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
Immunohistochemical expression of DNA repair proteins in familial breast cancer differentiate BRCA2-associated tumorsEmiliano Honrado, Ana Osorio, José Palacios, et al.Gastroenterology|March 10, 2009
Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progressionCarla Oliveira, Sónia Sousa, Hugo Pinheiro, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 13, 2009
IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtypeMartin Köbel, Haodong Xu, Patricia A Bourne, et al.Bioinformatics (Oxford, England)|February 5, 2010
SNVMix: predicting single nucleotide variants from next-generation sequencing of tumorsRodrigo Goya, Mark G F Sun, Ryan D Morin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2006
Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survivalMaggie C U Cheang, Diana O Treaba, Caroline H Speers, et al.Differentiation; Research in Biological Diversity|May 26, 2004
Epithelio-mesenchymal transition in a neoplastic ovarian epithelial hybrid cell lineSarah L Maines-Bandiera, David Huntsman, Valia S Lestou, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2009
Randomized phase II study comparing two schedules of everolimus in patients with recurrent/metastatic breast cancer: NCIC Clinical Trials Group IND.163Susan L Ellard, Mark Clemons, Karen A Gelmon, et al.BMC Cancer|December 20, 2014
Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomasAlicia A Tone, Melissa K McConechy, Winnie Yang, et al.Plos Medicine|December 5, 2008
Ovarian carcinoma subtypes are different diseases: implications for biomarker studiesMartin Köbel, Steve E Kalloger, Niki Boyd, et al.Pageof 15